GenePath Diagnostics
PrivateLast Round
Grant
Nov 23, 2020
Est. Valuation
$3.47M
Total Funding Raised
$2.19M
Company Overview
GenePath Diagnostics is a biotechnology company that develops and manufactures in vitro molecular diagnostic kits and provides clinical genomic testing services for infectious diseases, oncology, and genetic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenePath Diagnostics Comparables
Compare GenePath Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Huwel Lifesciences | 88% | |
| NeoDx Biotech Labs | 86% | |
| Genes2Me | 84% |
GenePath Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 23, 2020 | ||||
| Seed | Feb 1, 2016 |
Key People
Founding team and executive leadership
GenePath Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Saama Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors grew 163% MoM.
- Jan 5, 2026
Monthly visitors increased 36% MoM.
GenePath Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GenePath Diagnostics's valuation, stock price, and market status.
Is GenePath Diagnostics a public or private company?
GenePath Diagnostics is a private company.
What is the current stock price of GenePath Diagnostics?
GenePath Diagnostics is a private company with no public stock price. No recent secondary market data is available.
How much is GenePath Diagnostics worth (valuation)?
GenePath Diagnostics's valuation is estimated at $3.5M based on funding round data.
Can I buy GenePath Diagnostics stock?
GenePath Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GenePath Diagnostics's last funding round?
GenePath Diagnostics's most recent funding round was Grant on February 1, 2016.
Who are the main investors in GenePath Diagnostics?
Key investors in GenePath Diagnostics include Saama Capital.
Will GenePath Diagnostics IPO soon?
No public IPO plans have been announced for GenePath Diagnostics.
How can I track GenePath Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GenePath Diagnostics's secondary market activity and sign up for updates.